ORGS logo

Orgenesis Inc. (ORGS)

Profile

Full Name

Orgenesis Inc.

Ticker

NASDAQ: ORGS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 13, 2012

Indexes

Not included

Website

https://orgenesis.com

Employees

146

Key Details

Price

$1.00(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$530.00K(-98.53% YoY)

Annual EPS

-$19.10(-223.73% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.00
    ORGS price is $1.00

    30-Day Relative Volume

    0.00
    ORGS 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    0%
    ORGS price has remained unchanged on Aug 29, 2025

    Price YTD change

    -47.09%
    ORGS price is down -47.09% since January 1st

    Price 1-year change

    -85.51%
    ORGS price is down -85.51% year-on-year

    Price 3-year change

    -94.71%
    ORGS price is down -94.71% over the past 3 years

    Price Range

    Price All-time high

    $199.20
    ORGS price is currently -99.50% below its historical high of $199.20

    Price 3-year low

    $0.02
    ORGS price is currently +4900.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $5.17M
    ORGS market capitalization is $5.17 million

    Market cap 3-year change

    -89.29%
    ORGS market capitalization is down -89.29% over the past 3 years

    Market cap All-time high

    $195.54M
    ORGS market capitalization is currently -97.36% below its historical high of $195.54 million

    Market cap sector rank

    10.2%
    ORGS market capitalization is higher than 10.2% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +10.16%
    ORGS shares outstanding is up +10.16% year-on-year

    Shares Outstanding 3-Year Change

    +102.35%
    ORGS shares outstanding is up +102.35% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -19.47
    ORGS beta is -19.47

    200-day SMA

    $1.73
    ORGS price is currently -42.32% below its 200-day simple moving average

    50-day SMA

    $0.87
    ORGS price is currently +14.44% above its 50-day simple moving average

    RSI

    56.13
    ORGS 14-day relative strength index is 56.13

    Volume

    0.00
    ORGS 30-day relative volume is 0.00

    ATR

    $0.50
    ORGS average true range is $0.50

    10-day Historical Volatility

    24.26K%
    ORGS 10-day historical volatility is 24.26 thousand%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $530.00K
    ORGS annual revenue is $530.00 thousand

    Revenue Analysts estimate

    $70.30M
    ORGS annual revenue is currently -99.25% lower than the consensus analysts' forecast

    Revenue 1-year change

    -98.53%
    ORGS annual revenue is down -98.53% year-on-year

    Revenue Sector rank

    35.06%
    ORGS annual revenue is higher than 35.06% of companies in Healthcare sector

    EPS

    EPS

    -$19.10
    ORGS annual earnings per share is -$19.10

    EPS Analysts estimate

    -
    ORGS annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -223.73%
    ORGS annual earnings per share is down -223.73% year-on-year

    EPS Sector rank

    7.89%
    ORGS annual earnings per share is higher than 7.89% of companies in Healthcare sector

    Profit

    Gross profit

    -$5.72M
    ORGS annual gross profit is -$5.72 million

    Gross margin

    -1283.77%
    ORGS annual gross profit margin is -1283.77%

    Operating profit

    -$54.89M
    ORGS annual operating income is -$54.89 million

    Operating margin

    -10.36K%
    ORGS annual operating profit margin is -10.36 thousand%

    Net income

    -$64.92M
    ORGS annual net profit is -$64.92 million

    Net margin

    -12.25K%
    ORGS annual net profit margin is -12.25 thousand%

    Expenses

    Total expenses

    $55.42M
    ORGS annual total expenses is $55.42 million

    Operating expenses

    $49.17M
    ORGS annual total operating expenses is $49.17 million

    Cost of goods sold

    $6.25M
    ORGS annual cost of goods sold is $6.25 million

    Selling, general & administrative expenses

    $35.09M
    ORGS annual SGA is $35.09 million

    Depreciation and amortization

    $1.56M
    ORGS annual depreciation & amortization is $1.56 million

    Interest expense

    $0.00
    ORGS annual interest expense is $0.00

    Income tax

    $473.00K
    ORGS annual income tax is $473.00 thousand

    EBIT & EBITDA

    EBIT

    -$62.28M
    ORGS annual earnings before interest & taxes is -$62.28 million

    EBITDA

    -$60.72M
    ORGS annual EBITDA is -$60.72 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $14.55M
    ORGS annual total assets is $14.55 million

    Non current assets

    $10.48M
    ORGS annual long term assets is $10.48 million

    Current assets

    $4.08M
    ORGS annual total current assets is $4.08 million

    Cash and cash equivalents

    $837.00K
    ORGS annual cash & cash equivalents is $837.00 thousand

    Accounts receivable

    $88.00K
    ORGS annual accounts receivable is $88.00 thousand

    Inventory

    $34.00K
    ORGS annual inventory is $34.00 thousand

    Liabilities

    Total liabilities

    $35.53M
    ORGS annual total liabilities is $35.53 million

    Long term liabilities

    $19.13M
    ORGS annual total long term liabilities is $19.13 million

    Current liabilities

    $16.41M
    ORGS annual total current liabilities is $16.41 million

    Accounts payable

    $6.58M
    ORGS annual accounts payable is $6.58 million

    Debt

    Total debt

    $22.62M
    ORGS annual total debt is $22.62 million

    Total debt 1-year change

    +11.59%
    ORGS annual total debt is up +11.59% year-on-year

    Long term debt

    $19.07M
    ORGS annual long term debt is $19.07 million

    Short term debt

    $3.55M
    ORGS annual short term debt is $3.55 million

    Equity & Capital

    Shareholders equity

    -$20.98M
    ORGS annual stockholders equity is -$20.98 million

    Book value

    -$20.98M
    ORGS annual book value is -$20.98 million

    Retained earnings

    -$176.62M
    ORGS annual retained earnings is -$176.62 million

    Working capital

    -$12.33M
    ORGS annual working capital is -$12.33 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$14.84M
    ORGS annual cash flow from operations is -$14.84 million

    Cash from operations 1-year change

    +40.47%
    ORGS annual cash flow from operations is up +40.47% year-on-year

    Cash from investing

    -$3.71M
    ORGS annual cash flow from investing activities is -$3.71 million

    Cash from investing 1-year change

    +73.77%
    ORGS annual cash flow from investing activities is up +73.77% year-on-year

    Cash from financing

    $13.62M
    ORGS annual cash flow from financing activities is $13.62 million

    Cash from financing 1-year change

    -65.59%
    ORGS annual cash flow from financing activities is down -65.59% year-on-year

    CAPEX

    CAPEX

    $2.10M
    ORGS annual capital expenditures is $2.10 million

    CAPEX 1-year change

    -83.12%
    ORGS annual capital expenditures is down -83.12% year-on-year

    Free Cash Flow

    Free cash flow

    -$16.93M
    ORGS annual free cash flow is -$16.93 million

    Free cash flow 1-year change

    +54.65%
    ORGS annual free cash flow is up +54.65% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -1283.77%
    ORGS annual gross profit margin is -1283.77%

    Operating margin

    -10.36K%
    ORGS annual operating profit margin is -10.36 thousand%

    Net margin

    -12.25K%
    ORGS annual net profit margin is -12.25 thousand%

    ROA & ROE

    ROA

    -123.09%
    ORGS annual return on assets is -123.09%

    ROE

    -339.08%
    ORGS annual return on equity is -339.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ORGS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ORGS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.22
    ORGS price to book ratio is -0.22

    PB ratio Sector rank

    13.22%
    ORGS price to book ratio is higher than 13.22% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.75
    ORGS price to sales ratio is 5.75

    PS ratio Sector rank

    61.84%
    ORGS price to sales ratio is higher than 61.84% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $21.34M
    ORGS enterprise value is $21.34 million

    Enterprise value Sector rank

    29.52%
    ORGS enterprise value is higher than 29.52% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.70
    ORGS EV/EBITDA is -0.70

    EV/EBITDA Sector rank

    51.33%
    ORGS EV/EBITDA is higher than 51.33% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.25
    ORGS annual current ratio is 0.25

    Quick ratio

    0.25
    ORGS annual quick ratio is 0.25

    Leverage

    Debt to equity

    -1.08
    ORGS annual debt to equity ratio is -1.08

    Interest coverage ratio

    -
    ORGS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    ORGS piotroski f-score is 3

    Altman Z-Score

    -32.01
    ORGS altman z-score is -32.01

    Analyst ratings

    Recent major analysts updates

    Jun 14, 23 Benchmark
    Speculative Buy
    Mar 22, 23 Benchmark
    Buy
    Sep 26, 19 Benchmark
    Speculative Buy

    Institutional Ownership

    Screeners with ORGS included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Orgenesis Inc.?
    • Does Orgenesis Inc. pay dividends?
    • What sector is Orgenesis Inc. in?
    • What industry is Orgenesis Inc. in?
    • What country is Orgenesis Inc. based in?
    • When did Orgenesis Inc. go public?
    • Is Orgenesis Inc. in the S&P 500?
    • Is Orgenesis Inc. in the NASDAQ 100?
    • Is Orgenesis Inc. in the Dow Jones?
    • When was Orgenesis Inc.'s last earnings report?
    • When does Orgenesis Inc. report earnings?

    What is the ticker symbol for Orgenesis Inc.?

    The ticker symbol for Orgenesis Inc. is NASDAQ:ORGS

    Does Orgenesis Inc. pay dividends?

    No, Orgenesis Inc. does not pay dividends

    What sector is Orgenesis Inc. in?

    Orgenesis Inc. is in the Healthcare sector

    What industry is Orgenesis Inc. in?

    Orgenesis Inc. is in the Biotechnology industry

    What country is Orgenesis Inc. based in?

    Orgenesis Inc. is headquartered in United States

    When did Orgenesis Inc. go public?

    Orgenesis Inc.'s initial public offering (IPO) was on March 13, 2012

    Is Orgenesis Inc. in the S&P 500?

    No, Orgenesis Inc. is not included in the S&P 500 index

    Is Orgenesis Inc. in the NASDAQ 100?

    No, Orgenesis Inc. is not included in the NASDAQ 100 index

    Is Orgenesis Inc. in the Dow Jones?

    No, Orgenesis Inc. is not included in the Dow Jones index

    When was Orgenesis Inc.'s last earnings report?

    Orgenesis Inc.'s most recent earnings report was on November 13, 2024

    When does Orgenesis Inc. report earnings?

    The date for Orgenesis Inc.'s next earnings report has not been announced yet
    On this page